Status:
TERMINATED
MK0859 Dose-Ranging Study (0859-003)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hypercholesterolemia
Mixed Hyperlipemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
To assess the cholesterol changing effects of MK0859 in patients with primary hypercholesterolemia or mixed dyslipidemia.
Eligibility Criteria
Inclusion
- Eligible patients will be men and women of non-child bearing potential, 18 through 75 years of age diagnosed with high cholesterol
Exclusion
- Patients with CHD or CHD-equivalent disease (except diabetes)
- Diabetics on statins
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00325455
Start Date
June 1 2006
End Date
March 1 2007
Last Update
March 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.